The funding will allow CUH to buy new equipment for administering treatments such as CAR T-cell therapies, reducing patients' need to travel long distances.

Merus expects the FDA to make a decision on the application in February after reviewing additional manufacturing information it submitted.

Based on early Phase I/II trial data, Tango has decided to end enrollment in a study of TNG908 and focus resources on more promising drugs in its pipeline.

In JAMA Neurology, the group challenged the "movement" to define Alzheimer's disease as a "purely biological entity based on biomarker findings." ...

After years of persistence, genetic counselors at UT Southwestern got BCBS of Texas to fix a system error that was leading to payment denials for services.

National Cancer Center Japan has partnered with Precision Medicine Asia and Paradigm Health to develop a streamlined system to facilitate trials.

NEW YORK – Beam Therapeutics on Tuesday disclosed initial clinical data, including one patient death, in a Phase I/II trial of its investigational sickle cell disease (SCD) gene-editing therapy ...

NEW YORK – Inify Laboratories on Tuesday said it has partnered with researchers at Karolinska Institutet to improve prostate cancer diagnosis through artificial intelligence-driven image analysis.

The government payor said it will separately pay for specialized diagnostic radiopharmaceuticals without transitional pass-through payment status.

The FDA has cleared an investigational new drug application enabling the company to begin a Phase I trial of HG202 in patients with the eye disorder.

The drugmaker emphasized plans to move further away from singular reliance on Keytruda while reporting solid sales growth in ...

The company will use the funds to enroll a registrational trial for its investigational gene therapy NGN-401 for Rett Syndrome.